Optometrists in Bucyrus, OH Accepting Medicare

8 Optometrists found. Showing 1 - 8

Wayne H Collier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 905 S Poplar St, Bucyrus, OH 44820 Phone: 419-562-3822    Fax: 419-562-9939

Dr. Christina Marie Fox, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 236 S Sandusky Ave, Bucyrus, OH 44820 Phone: 419-562-0057    Fax: 419-562-0073

Dr. Jill Carlene Danker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 905 S Poplar St, Bucyrus, OH 44820 Phone: 419-562-3822

Envision Eyecare Llc Optometrist Medicare: Medicare Enrolled Practice Location: 236 S Sandusky Ave, Bucyrus, OH 44820 Phone: 419-562-0057    Fax: 419-562-0073

Thomas M Britton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1650 E Mansfield St, Bucyrus, OH 44820 Phone: 419-562-0744    Fax: 419-562-3861

Eyecare Optiques, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 905 S Poplar St, Bucyrus, OH 44820 Phone: 419-562-3822    Fax: 419-562-9939

Mr. Matthew Paul Axline, OD OPTOMETRIST Optometrist Medicare: Accepting Medicare Assignments Practice Location: 905 S Poplar St, Bucyrus, OH 44820 Phone: 419-562-3822    Fax: 419-562-9939

Club View Vision Center, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1650 E Mansfield St, Bucyrus, OH 44820 Phone: 419-562-0744    Fax: 419-562-3861

News Archive

Capitol Hill event highlights U.S. advancements in malaria science, technology

This post in Malaria No More's "Malaria Policy Center" blog reports on a two-part event held on Capitol Hill on Wednesday, April 25, World Malaria Day, titled, "U.S. Advancements in Science and Technology in Malaria: A Showcase of Domestic Research & Development to Save Lives and Keep Americans Safe."

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NanoPacific Holdings, Inc. (NPH) announces the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement between NPH and UCLA, NPH will have an exclusive worldwide license of a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles.

Combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancer

A clinical trial evaluating the benefit of adding the drug sorafenib to the combination of carboplatin/paclitaxel chemotherapy for lung cancer patients has been stopped based on results from an interim analysis, after an independent data monitoring committee concluded that the study would not meet its primary endpoint of improved overall survival.

Study finds, 70% of women are not gaining a healthy amount of weight during pregnancy

According to a study published by JAMA, weight gain during pregnancy (gestational weight gain) that was above or below the guideline recommendations was linked with a higher risk of adverse maternal and infant outcomes, compared with weight gain within recommended levels.

Read more Medical News

› Verified 6 days ago